Invitation to the public defense of the doctoral dissertation of Hannes Leupe
Hannes Leupe has the pleasure to invite you to the public defense of his doctoral dissertation.
Date: Wednesday September 30th, 2026, at 16:00h.
Location: Auditorium Arenbergkasteel, Kardinaal Mercierlaan 94, 3001 Leuven
3rd BELNUC Radioligand Therapy Course
3rd BELNUC Radioligand Therapy Course
- Date: November 28, 2026
- Venue: Sheraton Brussels Airport, 1930 Brussels, Belgium
Registration is now open!
The Deadline for registration is on November 20, 2026 (23:59 CET)
| Participant / Ticket Type | Early Registration (until 18/10/2026) |
Late Registration (19/10 until 20/11/2026) |
|---|---|---|
| BELNUC Member | 110 € | 175 € |
| Non-Member | 175€ | 225€ |
| BELNUC Technologist Member | 75€ | 125€ |
| Technologist Non-Member | 100 € | 150 € |
| Student / Resident | 50 € | 75 € |
| Optional parking voucher Brussels Airport Interparking (P1 Front Park, P2 Economy, or P3 Holiday parking) |
10€ | 10€ |
The industry exhibition setup will be published in due time.
Same format, Same place, More great content!
We are extremely pleased to announce the 3rd BELNUC Radioligand Therapy Course, taking place on Saturday, 28 November 2026 at the Sheraton Brussels Airport Hotel.
The annual BELNUC Radioligand Therapy Course is rapidly establishing itself as a leading educational event in the clinical practice of targeted radionuclide therapy in Belgium.
Following the highly successful first edition in 2024 and last years second edition in 2025, which brought together over 200 participants, 13 industry exhibitors and 17 expert speakers, and received overwhelmingly positive feedback, this third edition will again welcome a multidisciplinary audience of clinicians, physicists, radiopharmacists, nurses, technologists, industry representatives and experts involved in radioligand therapy (RLT) combined with interactive case based and panel discussions.
The BELNUC RLT Course offers a rich platform for sharing practical insights, clinical challenges, and forward-looking innovations in RLT delivery. Participants will benefit from engaging lectures, expert-led case discussions, and valuable opportunities to connect with peers and industry partners.
New this year is the opportunity for participants to present their own challenging clinical cases.
Preliminary Programme
| MORNING PROGRAMME |
| MAIN AUDITORIUM | EXHIBITION/HANDS-ON AREA | |
| 08:30-09:00 |
Registration & Welcome |
|
| 09:00-10:30 | Back to basics Moderator: prof. dr. Tim Van den Wyngaert 09:00-09:30: Designing biological effect in RLT: state-of-the-art in therapeutic radiopharmaceuticals. 09:30-10:00: Radiobiology for clinicians: why RLT works – or fails – across radionuclides. 10:00-10:30: Conversation with the Experts: From Evidence to Practice |
Exhibitor setup |
| 10:30-11:00 |
Coffee Break |
Dosimetry/Equipment demonstrations |
| 11:00-12:15 | Challenging cases in PRRT Moderator: dr. Niloefar Ahmadi Bidakhvidi Interactive case discussion + bring your own case |
Dosimetry/Equipment demonstrations |
| 12:15-13:15 |
Lunch |
Exhibition |
| AFTERNOON PROGRAMME |
| MAIN AUDITORIUM | EXHIBITION/HANDS-ON AREA | |
| 13:15-14:30 |
Challenging cases in mCRPC RLT Interactive case discussion + bring your own case |
|
| 14:30-15:00 |
Coffee Break |
Dosimetry/Equipment demonstrations |
| Excellence without exclusion: Organizing quality RLT care Moderator: prof. dr. Patrick Flamen 15:00-15:20 EARL Centres of Excellence (CoE) in RLT: quality framework or access 15:20-15:30 Results of the BELNUC-EARL benchmark survey 15:30-16:00 Conversation with the Experts: Controversies and Consensusbarrier in the Belgian landscape? |
Dosimetry/Equipment demonstrations |
Call for Challenging Cases
Got a case that kept you up at night? We want it!
The 3rd BELNUC Radioligand Therapy Course (Saturday 28 November 2026, Sheraton Brussels Airport) is opening its floor to you. We’re inviting challenging clinical cases in PRRT and mCRPC RLT for a short 5-minute presentation, followed by a lively, interactive discussion with our expert panel and the room.
Priority for young professionals (≤38 years)! If you’ve wrestled with a tricky case and have a question worth debating, we will give you priority on the stage. A friendly, high-level audience, real-time expert input, and a great line for your CV. No polished success stories required; the harder the case, the better the discussion.
What makes a great submission? A genuinely difficult real-world clinical management challenge, built around one clear question for the panel, with the relevant clinical context and supporting data (imaging, dosimetry, labs, follow-up).
Topics open for submission
- PRRT: non-NET indications, SSTR-positive/FDG-avid disease, transition from β- to α-emitters in NET
- PSMA-RLT: FDG-positive disease, toxicity management, complete/mixed response, oligoprogression, bone-only disease
How to get on stage
- Complete the Case Submission Form
- Add a short CV (max 1 page)
- Send it to Niloefar Ahmadi Bidakhvidi (PRRT) or Olivier De Winter (mCRPC RLT)
Deadline: Sunday 20 September 2026, 23:59 CET.
Selected presenters notified by October 1st.
We welcome your real-world contributions and look forward to a stimulating scientific exchange!
We would like to thank all Sponsors of the 3rd BELNUC RLT Course!
How to use the parking voucher?
- Use one of the following parking facilities at Brussels Airport: P1 Front Park, P2 Economy, or P3 Holiday parking. The voucher can only be used at these parkings.
- Take your parking ticket at the entrance.
- Collect your voucher at the BELNUC registration desk.
- Upon your return, go to one of the payment machines of your parking before retrieving your vehicle.
- Insert your parking ticket into the payment machine first, followed by your voucher. Pay any remaining balance if applicable. Take your ticket back, as you will need it to exit the parking.
FANC/AFCN has accredited:
- 5u00 for Nuclearisten/Nucléaristes
- 5u00 for Stralingsfysicus NG/Radiophysiciens MN
- 2u00 for Gemachtigden NG/Personnes Habilitées MN
RIZIV/INAMI accreditation has been requested, including Ethics & Economy.
FOD/SPF accreditation for hospital pharmacists has been requested.
Technologist Day 2026 – November 21, 2026
Date: Saturday, November 21, 2026
Time: 09:00-16:00
Venue: De Montil – Moortelstraat 8, 1790 Affligem
Registration Types & Fees
The TechDay will have a “Dutch” and a “French” program. Please choose the correct ticket for you when registering. The fees are of course the same.
The Registration is now open!
The Deadline for Registration is on November 13, 2026 (23:59 CET)!
To register yourself for the event, follow the steps of the “How to: Event Registration” guide.
To register a group for the event, follow the steps of the “How to: Group Registration” guide.
| Ticket Dutch / French Early Registration (until November 01) |
Ticket Dutch / French Late Registration (November 02 – 13) |
|
| Members | €100 | €150 |
| Non-Members | €140 | €200 |
| Students | Free | Free |
Preliminary Program
DUTCH PROGRAM
| Time | Panel | Speaker |
|---|---|---|
| 09:00 – 09:15 | Welcoming Session | |
| 09:15 – 10:00 | How does dosimetry work in NM? | Matthijs Sevenois (UZ Leuven) |
| 10:00 – 10:30 | Non onco bone scan and MSK disorders | Ludovic D’hulst (AZ Sint-Lucas) |
| –Coffee Break– | ||
| 11:00 – 11:30 | Breast cancer and NM | Martin Manley (Reinier de Graaf Ziekenhuis Delft) |
| 11:30 – 12:15 | Do bone scans still have a place in the era of PSMA PET? | Lieselot Brepoels (UZ Ghent) |
| —Lunch— | ||
| 14:00 – 14:45 | 18-FDG hybrid PET use in infection and inflammation in adults | Olivier Gheysens (UC Louvain) |
| 14:45 – 15:30 | From breast to melanoma and beyond: lymphocintigraphy as a compass in oncological surgery | Sara Ceyssens (AZ Klina) |
| 15:30 – 16:00 | Clinical Cases | Justine Maes (UZ Leuven) |
FRENCH PROGRAM
| Time | Panel | Speaker |
|---|---|---|
| 09:00 – 09:15 | Welcoming Session | |
| 09:15 – 10:00 | How does dosimetry work in NM? | Clémentine Marin (HU Bruxelles) |
| 10:00 – 10:30 | Non onco bone scan and MSK disorders | Nicolas Gohimont (Grand-Hôpital de Charleroi) |
| –Coffee Break— | ||
| 11:00 – 11:30 | Breast cancer and NM | Isabel Marin-Melero (Clinique Notre Dame de Grace) |
| 11:30 – 12:15 | 18-FDG hybrid PET use in infection and inflammation in adults | Olivier Gheysens (UC Louvain) |
| —Lunch— | ||
| 14:00 – 14:45 | Do bone scans still have a place in the era of PSMA PET? | Camille Steenhout (CHU de Liège) |
| 14:45 – 15:30 | From breast to melanoma and beyond: lymphocintigraphy as a compass in oncological surgery | Gerard Thomas (UC Louvain) |
| 15:30 – 16:00 | Clinical Cases | Max Lonneux (Chirec) |
Please note that this is a Provisional Program. Changes in the program can occur.
FANC/AFCN Accreditation has accredited:
- 4u30 for Nuclearisten/Nucléaristes
- 4u30 for Gemachtigden NG/Personnes Habilitées MN
BELNUC, BSMO, BeSTRO and BMUC Webinar -Standardising PSMA PET/CT Reporting in Belgium
Date: June 09, 2026
Time: 18:00 – 19:30
Venue: Webinar – online via Zoom
— Click here to register now! —
Can we standardise PSMA PET/CT reporting across Belgium?
Open to all Physicians involved in Management of Prostate Cancer
Organised by the Belgian Association of Nuclear Medicine in
collaboration with BSMO, BeSTRO, BMUC, SBU and BVU.
Register now
Invitation to the Belgian RLT Summit
The Belgian RLT Summit 2026:
A Unified National Strategy for
Radioligand Therapy
Nederlandse versie (Version française ci-dessous – English version below)
Geachte mevrouw,
Geachte heer,
SCK CEN nodigt u uit voor The Belgian RLT Summit 2026, een interfederaal forum over de toekomst van radioligandtherapie (RLT) in België.
België speelt een sleutelrol in de ontwikkeling en uitrol van RLT, een van de meest veelbelovende innovaties binnen de nucleaire geneeskunde en oncologische zorg. Dankzij een uitzonderlijk sterk en geïntegreerd ecosysteem, van de productie van radio-isotopen en farmaceutische innovatie tot gespecialiseerde ziekenhuiszorg, beschikt ons land over alle troeven om toonaangevend te zijn in Europa.
Met dit forum willen wij beleidsmakers, clinici, academici, industrie en bevoegde autoriteiten samenbrengen om te werken aan een coherente en toekomstgerichte interfederale strategie voor RLT. Onze gezamenlijke ambitie moet zijn om zowel de toegang van patiënten tot deze therapie te waarborgen als de leidende positie van het Belgische ecosysteem te versterken en te bestendigen.
Programma:
09.00 – 09.05: Welkom door Sarah Baatout (SCK CEN)
09.05 – 09.20: Politieke opening door Minister van Energie, Mathieu Bihet
09.20 – 09.35: Wetenschappelijke keynote door Professor Bertrand Tombal (European Organisation for Research and Treatment of Cancer)
—
09.35 – 10.05: Panel I – What does it take? (NL/FR)
Paneldiscussie gemodereerd door Ingrid Maes (Inovigate) met o.a. Koen Dillen (N-VA), Irina de Knop (Anders), Florence Pottiez (MR), Professor Christophe Deroose (UZ Leuven), Dr. Hugues Malonne (FAGG/AFMPS/FAMHP) en André Deschamps (Voorzitter Wij Ook)
—
10.35 – 11.15: Panel II – How do we move forward? (NL/FR)
Paneldiscussie gemodereerd door Ingrid Maes (Inovigate) met o.a. Professor Nadia Withofs (BELNUC), Kathleen Depoorter (N-VA), Tina Van Havere (Vooruit), Professor Piet Dirix (ZAS) en Marie Jacqmin (Les Engagés)
—
11.15 – 11.25: Fireside chat with Ben Gommers (Novartis): Learnings from the Australian RLT scene (ENG)
—
11.25 – 12.05: Panel III – From political ambition to implementation (NL/FR)
Paneldiscussie gemodereerd door Ingrid Maes (Inovigate) met o.a. Koen Hasaers (SCK CEN), Professor Evandro de Azambuja (BSMO), Professor Ken Kudura (BELNUC), Professor Lieselot Brepoels (TRRI) en Wouter Beke (MEP CD&V)
12:05 – 12.15: Closing remarks – Marc Van den Bulcke (Sciensano)
12.15 – 13.00: Netwerklunch
Praktische informatie
- Datum: maandag 30 maart 2026
- Tijdstip: 09.00 – 12.15 uur, gevolgd door een netwerklunch
- Locatie: Paleis der Academiën, Hertogsstraat 1, 1000 Brussel
- Taal: Nederlands en Frans, tolken aanwezig voor simultane vertaling
Wij hopen u op 30 maart te mogen verwelkomen. Gelieve uw aanwezigheid te bevestigen via deze inschrijvingslink.
Ik schrijf me in
Met hoogachting,
Sarah Baatout
Deputy Institute Director of Nuclear Medical Applications
SCK CEN
Koen Hasaers
Institute Director of Nuclear Medical Applications
SCK CEN
Met de steun van Novartis
Version française
Madame,
Monsieur,
Le SCK CEN a le plaisir de vous inviter au Belgian RLT Summit 2026, un forum interfédéral consacré à l’avenir de la radioligand-thérapie (RLT) en Belgique.
La Belgique joue un rôle clé dans le développement et le déploiement de la RLT, l’une des innovations les plus prometteuses en médecine nucléaire et en oncologie. Notre pays est aujourd’hui un leader européen grâce à un écosystème exceptionnellement solide et intégré, allant de la production de radio-isotopes et de l’innovation pharmaceutique aux soins hospitaliers hautement spécialisés.
À travers ce forum, nous souhaitons réunir décideurs politiques, cliniciens, universitaires, acteurs industriels et autorités compétentes afin de travailler à une stratégie interfédérale cohérente et tournée vers l’avenir pour la RLT. Notre ambition commune doit être d’assurer l’accès des patients à cette thérapie tout en renforçant et en consolidant la position de leader de l’écosystème belge.
Programme:
09.00 – 09.05: Mot de bienvenue par Sarah Baatout (SCK CEN)
09.05 – 09.20: Ouverture politique par le Ministre de l’Énergie, Mathieu Bihet
09.20 – 09.35: Keynote scientifique par Professeur Bertrand Tombal (European Organisation for Research and Treatment of Cancer)
—
09.35 – 10.05: Panel I – What does it take? (FR/NL)
Discussion panel modérée par Ingrid Maes (Inovigate) avec notamment Koen Dillen (N-VA), Irina de Knop (Anders), Florence Pottiez (MR), Professeur Christophe Deroose (UZ Leuven), Dr. Hugues Malonne (FAGG/AFMPS/FAMHP) et André Deschamps (Voorzitter Wij Ook)
—
10:05 – 10:35: Pause
—
10.35 – 11.15: Panel II – How do we move forward? (FR/NL)
Discussion panel modérée par Ingrid Maes (Inovigate) avec notamment Professeur Nadia Withofs (BELNUC), Kathleen Depoorter (N-VA), Tina Van Havere (Vooruit), Professeur Piet Dirix (ZAS) et Marie Jacqmin (Les Engagés)
—
11.15 – 11.25: Fireside chat with Ben Gommers (Novartis): Learnings from the Australian RLT scene (ENG)
—
11.25 – 12.05: Panel III – From political ambition to implementation (FR/NL)
Discussion panel modérée par Ingrid Maes (Inovigate) avec notamment Koen Hasaers (SCK CEN), Professeur Evandro de Azambuja (BSMO), Professor Ken Kudura (BELNUC), Professeur Lieselot Brepoels (TRRI) et Wouter Beke (MEP CD&V)
12.05 – 12.15: Mot de clôture – Marc Van den Bulcke (Sciensano)
12.15 – 13.00: Déjeuner de réseautage
Informations pratiques
- Date : lundi 30 mars 2026
- Horaire : 09.00 – 12.15, suivi d’un lunch de réseautage
- Lieu : Palais des Académies, Rue Ducale 1, 1000 Bruxelles
- Langue : néerlandais et français, avec interprétation simultanée
Nous espérons avoir le plaisir de vous accueillir le 30 mars. Nous vous remercions de bien vouloir confirmer votre présence via ce lien d’inscription.
Je m’inscris
Veuillez agréer, Madame, Monsieur, l’expression de nos salutations distinguées.
Sarah Baatout
Deputy Institute Director of Nuclear Medical Applications
SCK CEN
Koen Hasaers
Institute Director of Nuclear Medical Applications
SCK CEN
Avec le soutien de Novartis
English version
Dear Madam, Dear Sir,
SCK CEN is pleased to invite you to The Belgian RLT Summit 2026, an interfederal forum on the future of radioligand therapy (RLT) in Belgium.
Belgium plays a key role in the development and deployment of RLT, one of the most promising innovations in nuclear medicine and oncology care. Thanks to an exceptionally strong and integrated ecosystem, ranging from the production of radioisotopes and pharmaceutical innovation to highly specialised hospital care, our country has all the assets required to be a European leader in this field.
With this forum, we aim to bring together policymakers, clinicians, academics, industry representatives and competent authorities to work towards a coherent and forward-looking interfederal strategy for RLT. Our shared ambition must be to ensure patient access to this therapy while strengthening and consolidating the leading position of the Belgian ecosystem.
Program:
09.00 – 09.05: Welcome by Sarah Baatout (SCK CEN)
09.05 – 09.20: Political opening by the Minister of Energy, Mathieu Bihet
09.20 – 09.35: Scientific keynote by Professor Bertrand Tombal (European Organisation for Research and Treatment of Cancer)
—
09.35 – 10.05: Panel I – What does it take? (NL/FR)
Panel discussion moderated by Ingrid Maes (Inovigate) with, among others, Koen Dillen (N-VA), Irina de Knop (Anders), Florence Pottiez (MR), Professor Christophe Deroose (UZ Leuven), Dr. Hugues Malonne (FAGG/AFMPS/FAMHP) and André Deschamps (Voorzitter Wij Ook)
—
10.05 – 10.35: Break
—
10.35 – 11.15: Panel II – How do we move forward? (NL/FR)
Panel discussion moderated by Ingrid Maes (Inovigate) with, among others, Professor Nadia Withofs (BELNUC), Kathleen Depoorter (N-VA), Tina Van Havere (Vooruit), Professor Piet Dirix (ZAS) and Marie Jacqmin (Les Engagés)
—
11.15 – 11.25: Fireside chat with Ben Gommers (Novartis): Learnings from the Australian RLT scene (ENG)
—
11.25 – 12.05: Panel III – From political ambition to implementation (NL/FR)
Panel discussion moderated by Ingrid Maes (Inovigate) with, among others Koen Hasaers (SCK CEN), Professor Evandro de Azambuja (BSMO), Professor Ken Kudura (BELNUC), Professor Lieselot Brepoels (TRRI) and Wouter Beke (MEP CD&V)
12.05 – 12.15: Closing remarks – Marc Van den Bulcke (Sciensano)
12.15 – 13.00: Networking Lunch
Practical information
- Date: Monday, 30 March 2026
- Time: 09.00 – 12.15, followed by a networking lunch
- Venue: Academy Palace, Rue Ducale 1, 1000 Brussels
- Language: Dutch and French, with simultaneous interpretation available
We look forward to welcoming you on the 30th of March. Kindly confirm your attendance via this registration link.
Register here
Yours sincerely,
Sarah Baatout
Deputy Institute Director of Nuclear Medical Applications
SCK CEN
Koen Hasaers
Institute Director of Nuclear Medical Applications
SCK CEN
With the support of Novartis
A warm welcome to our new BELNUC Board!
We would like to welcome our new BELNUC Board that has been elected during our annual BELNUC General Assembly (March 14, 2026)!
- Max LONNEUX has been elected as our new President-elect (2026-2027)
- Stijn VAN HECKE has been elected as our new General Secretary-elect (2026-2027)
- Niloefar AHMADI BIDAKHVIDI has been elected as our new Regular Board Member (2026-2028)
We would like to give some special thanks to Nadia Withofs (President 2024-2025), Vanessa Schelfhout (General Secretary 2024-2025) and Mariana Andrade (Board Member 2023-2025) for their contribution to the BELNUC in their respective positions as Board Members in the past years.
The current BELNUC Board composition can be found on our BELNUC Board website.
BELNUC Board (March 14, 2026)
Announcement of the applicants for the BELNUC Board 2026!
|
During the 2026 General Assembly (14/03/2026), the BELNUC members will elect new Board members:
Please let me introduce you to the applicants for the BELNUC Board: President-elect:
General Secretary-elect:
Regular Board Member:
|
Save the Date: 2nd BELNUC Glamping Weekend
Date: September 11-13, 2026
Get ready to unplug and level up! Prepare for a unique glamping weekend fueled by career growth, hands-on learning, and community vibes for young professionals and students passionate about nuclear medicine. Think skill-building workshops, future-focused discussions (yes, including AI), teambuilding under the stars, and connections that actually matter, all set in a chill nature retreat. The new location will be revealed shortly!
Whether you’re a curious student or an early-career resident, this is your chance to discover, connect, and grow in a space that feels more like an experience than a meeting.
More information will follow in due time!
Joint BELNUC–BWGNICI Cardiology Seminar
Joint BELNUC–BWGNICI Cardiology Seminar
Cardio-Nuclear Synergy in Practice
Saturday, September 26, 2026
Crown Plaza Brussels Airport
On Saturday, 26 September 2026, BELNUC and BWGNICI will jointly organize a dedicated Cardiology Seminar, bringing together experts in nuclear cardiology and cardiovascular imaging.
This seminar will include state-of-the-art cardiac imaging, interdisciplinary collaboration between nuclear medicine and cardiology, and evolving clinical applications in daily practice. A detailed scientific program, speakers, and registration information will follow.
Registration
The registration is now open!
The deadline for registration is September 20, 2026 (23:59 CET)!
| Registration Type | Registration Fee |
|---|---|
| BELNUC Member | 0 € |
| BELNUC Non-Member | 50 € |
| Student | 0 € |
| BSC Member | 0€ |
Preliminary Program
| 08:30 – 09:00 | Registration & Coffee |
| 09:00 – 09:05 | Welcome & Introduction (R. Dulgheru & O. Gheysens) |
Session 1 : Advanced Imaging in Chronic Coronary Syndromes: beyond the lumen
| Time | Panel | Speaker |
|---|---|---|
| Moderators: C. Van de Heyning & P. De Bondt | ||
| 09:05 – 09:25 | CCTA/CT perfusion : seeing anatomy and flow in one view | R. Symons (Imelda Ziekenhuis Bonheiden) |
| 09:25 – 09:45 | Stress MRI : seeing ischemia without radiation | A. Chiribiri (King’s College London, United Kingdom) |
| 09:45 – 10:05 | SPECT/PET quantification : from images to numbers | A. Saraste (Turku University Hospital, Finland) |
| 10:00 – 10:30 | Panel discussion | |
| 10:30 – 11:00 | Coffe Break |
Intermezzo – PRO / CON DEBATE
| Time | Panel | Speaker |
|---|---|---|
| Moderators: P. Bertrand – O. Gheysens | ||
| “All AS patients with concentric LVH should be screened for cardiac amyloidosis” |
||
| 11:00 – 11:05 | PRO | K. Dujardin (AZ Delta, Roeselare) |
| 11:05 – 11:10 | CONTRA | S. Kautbally (Cliniques universitaires Saint-Luc) |
| 11:10 – 11:25 | Discussion |
Session 2 : Infective Endocarditis: Role of PET-CT in Clinical Decision-Making
| Time | Panel | Speaker |
|---|---|---|
| Moderators: V. Roelants – B. Paelinck | ||
| 11:30 – 11:45 | Cases Presentation – Infective Endocarditis in the hot seat | O. de la Brassinne Bonardeaux (CHU Liège) |
| 11:45 – 12:00 | The echo roadmap in infective endocarditis and CIED infections | K. Goossens (VITAZ Sint-Niklaas) |
| 12:00 – 12:25 | Lighting up infection : PET-CT(A) in complex infective endocarditis and CIED infections | M. Pizzi (University Hospital Vall d’Hebron, Barcelona, Spain) |
| 12:25 – 12:40 | From guidelines to bedside | A. Pasquet (Cliniques universitaires Saint-Luc) |
| 12:40 – 12:55 | Panel discussion | |
| 12:55 – 13:00 | Closing remarks | BELNUC & BWGNICI Chairs |
FANC/AFCN has accredited:
- 2u00 for Nuclearisten/Nucléaristes
- 2u00 for Radiologen/Radiologues
- 2u00 for Connexisten/Connexistes
General Assembly and Seminar – March 14, 2026
- Date: Saturday, March 14, 2026
- Venue: Crown Plaza Brussels Airport
CP for RIZIV/INAMI will be requested. CP in Ethics & Economy will be requested1.
Accreditation for Hospital Pharmacists (2 points in module 4 & 5) has been granted.
FANC/AFNC has granted:
- 2u00 voor Nuclearisten
- 2u00 voor Stralingsfysicus NG
- 2u00 voor Gemachtigden NG
- 2u00 voor Radiofarmaceuten
The registration is now open! Click here to register now!
Registration will close on March 08, 2026.
BELNUC Members can attend the Seminar free of charge.
BELNUC Non-Members have to pay a fee of 50€ to attend the Seminar.
Please let me remind you that the Seminar fee for BELNUC members is free!
The renewal of the BELNUC Membership via invoice payment may take up to 10 days. Therefore, please make sure to renew your BELNUC membership in due time!
During the General Assembly, there will be votings for the following positions:
- President-elect
- General Secretary-elect
- BELNUC Board Member
The applicants for the positions in the BELNUC Board can be found here.
Only valid BELNUC Members are allowed to participate in the voting process.
The renewal of the BELNUC Membership via invoice payment may take up to 10 days. Therefore, please make sure to renew your BELNUC membership in due time!
Preliminary Program
08:30-08:50: Welcome
08:50-10:00: General Assembly
10:00-10:30: Coffee Break
PIC/S for 99mTc-based radiopharmaceuticals:
Moderators: Apr. Pieter De Jonghe (AZ Groeninge) & prof. dr. Tim Van den Wyngaert (UZA/UA)
10:35-11:00: Experiences from two centres’ PIC/S journey: From theory to practice – Apr. Nele Cromphout (AZORG)
11:00-12:30: Multi-stakeholder panel discussion on the path towards PIC/S implementation in Belgium
- VBS representative (dr. Raf Verscuren)
- FAGG representative (Margriet Gabriels, Emmanuelle Gay)
- BVZA representative (prof. apr. Thomas De Rijdt)
- BARR representative (prof. apr. Vicky Caveliers)
- Captains of industry (GE & Curium)
This session addresses the implications of implementing PIC/S requirements in nuclear medicine practice through real-world case studies and a multi-stakeholder panel discussion. By presenting the PIC/S implementation journeys of both a small peripheral hospital and a medium-to-large center, the session illustrates how to tackle the challenges of PIC/S with respect to safeguarding patients access and managing economic impact. The subsequent panel discussion with representatives from professional societies (BELNUC, VBS/GBS), regulatory authorities (FAMHP), and industry explores shared accountability, regulatory ethics, cost-effectiveness, and sustainability of services. Together, these components provide participants with practical insight into ethically responsible and economically sustainable decision-making in a highly regulated healthcare environment.
All BELNUC members in good standing are cordially invited to attend the first 2026 seminar as well as the general assembly of our society on Saturday March 14th , 9:00 – 12:30. Only members in good standing can vote!
Travel/Parking
By Car:
Once on the A201 direction Zaventem Airport take the exit ‘Zaventem Centrum / Da Vinci’. At the roundabout, take the third exit following direction ‘Da Vinci’. Take the first exit left and follow the road through the tunnel. Straight ahead at the next roundabout and the hotel is located on the left.
Satellite Navigation: Da Vincilaan 4, 1831 Diegem
Free parking upon availability!